Tuesday, November 13, 2018 12:58:47 PM
Most of those early posts could be posted today and many are. The good thing is there are very few negative post when it comes to this company, most posts are about potential, never accused of being a scam or not true. I have been a stock holder for 11 years or more and my first post was #45 back in 2010.
I have made a very good profit on MYMX over the years, (selling near highs and buying near lows and a few mistakes in between) but always held some stock back. My average cost is still around .02-.03 a share. I probably have fewer shares now than I have ever had but that's because things have not changed much in the last 10 years. If culmination is about to happen the stock price is not showing it at this time. I've said many times its more about the politics of the science than the actual science. These companies aren't here to save the human race, they are here to make money, just like any tech company. My point being when other companies decide they can make money off of Mymetics technology they will. It is very surprising how little new breakthroughs have happened over the life of what Mymetics has brought to the table. Sometimes I think not curing diseases is more profitable than curing them but that's another story.
I still think the time my be near for a breakout here, only because nothing very new has happened over many years to discredit what M has brought to the table and I wait patiently.
Recent MYMX News
- Form 15-12G - Securities registration termination [Section 12(g)] • Edgar (US Regulatory) • 01/02/2024 06:16:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/28/2023 01:00:38 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 12/13/2023 05:15:20 AM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/20/2023 01:53:34 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/24/2023 08:42:46 PM
- Form SC 13E3 - Going private transaction by certain issuers • Edgar (US Regulatory) • 10/17/2023 07:08:56 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/11/2023 01:00:41 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/18/2023 10:02:57 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/31/2023 09:01:04 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM